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Indolmycin is a natural tryptophan analog that competes
with tryptophan for binding to tryptophanyl-tRNA synthetase
(TrpRS) enzymes. Bacterial and eukaryotic cytosolic TrpRSs
have comparable affinities for tryptophan (Km 2 M), and yet
only bacterial TrpRSs are inhibited by indolmycin. Despite the
similarity between these ligands, Bacillus stearothermophilus
(Bs)TrpRS preferentially binds indolmycin 1500-fold more
tightly than its tryptophan substrate. Kinetic characterization
and crystallographic analysis of BsTrpRS allowed us to probe
novel aspects of indolmycin inhibitory action. Previous work
had revealed that long range coupling to residues within an
allosteric region called the D1 switch of BsTrpRS positions the
Mg2 ion in a manner that allows it to assist in transition state
stabilization. TheMg2 ion in the inhibited complex forms sig-
nificantly closer contacts with non-bridging oxygen atoms from
each phosphate group of ATP and three water molecules than
occur in the (presumably catalytically competent) pre-transi-
tion state (preTS) crystal structures. We propose that this
altered coordination stabilizes a ground stateMg2ATPconfig-
uration, accounting for the high affinity inhibition of BsTrpRS
by indolmycin. Conversely, both the ATP configuration and
Mg2 coordination in the human cytosolic (Hc)TrpRS preTS
structure differ greatly from the BsTrpRS preTS structure. The
effect of these differences is that catalysis occurs via a different
transition state stabilizationmechanism in HcTrpRS with a yet-
to-be determined role for Mg2. Modeling indolmycin into the
tryptophan binding site points to steric hindrance and an inabil-
ity to retain the interactions used for tryptophan substrate rec-
ognition as causes for the 1000-fold weaker indolmycin affinity
to HcTrpRS.
The accumulation of resistance in pathogenic organisms
over time and with prolonged drug use necessitates the contin-
ued development of new anti-infective therapeutics. Such
developments can include modifications to current drugs that
are active against exploited targets while counteracting current
resistance mechanisms or novel compounds targeted against
underexploited targets. One group of enzyme targets that has
been validated but remains underexploited is the class of ami-
noacyl-tRNA synthetases (aaRSs).2 Aminoacyl-tRNA syntheta-
ses maintain the fidelity of the genetic code by ensuring the
charging of tRNA with its cognate amino acid via the following
two-step reaction.
aaRS  ATP  aa ¡ aaRSaa-AMP  PPi
REACTION 1
aaRSaa-AMP  tRNA ¡ aaRS  aa-tRNA  AMP
REACTION 2
All aaRS enzymes bind ATP and activate a specific amino
acid by catalyzing the formation of an aminoacyl 5-adenylate
(aa-AMP) during the first step. This is followed by transfer of
the activated amino acid to the 3-end of the correct tRNA.
Structural and mechanistic differences among the different
aaRS enzymes as well as orthologs of individual synthetases
make it possible to selectively modulate the activity of specific
synthetases, e.g. prokaryotic over eukaryotic TrpRS (1). This
makes the aaRS enzymes attractive targets for novel anti-infec-
tive therapeutics.
Any compounds intended for clinical use must be much less
inhibitory against the eukaryotic orthologs of its intended tar-
get. Naturally occurring aminoacyl-tRNA synthetase inhibitors
include indolmycin (TrpRS), granaticin (LeuRS), mupirocin
(IleRS), and ochratoxin A (PheRS) (1–4). Of these, mupirocin
displays the required selectivity for prokaryotic over eukaryotic
IleRS and has been developed for the treatment of infections in
humans (5).
Indolmycin produced by Streptomyces griseus displays selec-
tive inhibition for prokaryotic TrpRS (9 nM; Escherichia coli)
over eukaryotic TrpRS (4 mM; Bos taurus) (6). Problems with
off-target effects on tryptophan metabolism have prevented its
clinical use (7). However, if we could understand the molecular
basis for the observed inhibition and selectivitywe could exploit
this information for the rational design of antibiotics targeted
against TrpRS on pathogens.
Structurally, tryptophan and indolmycin are quite similar
with a heterocyclic indolemoiety at the root of each ligand (Fig.
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1). Indolmycin differs from tryptophan in the followingways. (i)
The carbon that is functionally equivalent to C is substituted
with a methyl group. (ii) The carbonyl carbon is part of an
oxazolinone ring. (iii) The hydroxyl and amine groups of tryp-
tophan are replaced by the nitrogen and oxygen atoms of the
oxazolinone ring, respectively. (iv) The -NH-CH3 moiety
attached to the oxazolinone ring does not have functionally
equivalent atoms in tryptophan.
BsTrpRS is one of the most extensively characterized TrpRS
enzymes. Mechanistically a Mg2 ion is linked to what appears
to be a dissociative transition state for tryptophan activation
(8–10). During catalysis, the Mg2 ion helps compensate for
the increased negative charge that develops on the PPi leaving
group, resulting from breaking the P–O–P bond. TheMg2
ion must move to be catalytically competent, but no protein-
metal interactions have been observed in any of the BsTrpRS
crystal structures determined. Instead, a remote allosteric loca-
tion, the D1 switch, must undergo significant conformational
change to promote the Mg2 ion to a catalytically competent
position. The metal moves closer to the PPi leaving group,
whose charge is further stabilized in the transition state by the
KMSKS loop. ATP binding is required for the conformational
switching between the open and closed states that allows for
catalysis. ATP-dependent induced fit closing of the active site
brings ATP 4 Å closer to tryptophan in a predominantly
translational movement mediated by relative movement of the
catalytic and anticodon-binding domains.
In the absence of ATP, tryptophan binding is promoted by
hydrophobic van derWaals interactions,- interactions with
Phe5, and a hydrogen bond between the indole nitrogen and
Asp132 of the specificity helix. When both substrates bind, the
tryptophan substrate undergoes a rotational movement that
brings the indole ring deeper into the binding pocket and
results inmore stabilizing interactions between tryptophan and
active site residues. This change is facilitated by the inward
movement of the specificity helix that is not observed when
only tryptophan is bound.
ATP-dependent induced fit rearrangement of the active site
facilitates proper ATP positioning in BsTrpRS, and molecular
dynamics simulations demonstrate that tryptophan is required to
achieve the requisite movement of the P in HcTrpRS (11, 12).
Even amodest substitution of tryptophanamide in place of trypto-
phan prevents the repositioning of ATP. These findings support
the idea that HcTrpRS is intrinsically better at discriminating
between tryptophan and its structural analogs than is BsTrpRS.
HcTrpRS uses different structural elements for substrate rec-
ognition than its prokaryotic orthologs (13). Such elements
include an extendedN terminus with a 1-2 hairpin structure
shown to have a role in ATP binding as well as the amino acid
activation reaction in HcTrpRS (14). In contrast to BsTrpRS, it
is tryptophan binding that leads to induced fit rearrangement of
the active site in HcTrpRS. There are a greater number of bind-
ing determinants for tryptophan recognition as eight direct and
water-mediated hydrogen bonds with polar side chains stabi-
lize tryptophan in the active site. It has been proposed that
amino acid activation proceeds via an associative transition
state in HcTrpRS with an unclear role of Mg2 in the catalytic
transition state (11). However, comparison of the pre-transi-
tion (Protein Data Bank code 2QUI) and product states (Pro-
teinData Bank code 2QUJ) shows that, as with BsTrpRS, theP
of ATP must move 5.3 Å to be in a position for nucleophilic
attack by tryptophan.
Despitemechanistic and structural differences, BsTrpRS and
HcTrpRS have comparable tryptophan binding affinities. How-
ever, these inherent differences between prokaryotic and
eukaryotic TrpRS enzymes promote the binding of indolmycin
to prokaryotic TrpRSs1500-fold while protecting eukaryotic
TrpRSs from such inhibition by a comparable amount. Deter-
mining the structure of BsTrpRS bound by Mg2ATP and
indolmycin allowed us to probe the structural basis for indol-
mycin inhibition and selectivity. Specifically, we examined this
structure along with the catalytically relevant structures of
BsTrpRS and HcTrpRS deposited in the Protein Data Bank to
answer the following questions. 1)What are the structural con-
sequences of binding indolmycin? 2)Why is indolmycin a tight
inhibitor of prokaryotic TrpRS? 3) Why is indolmycin not an
inhibitor of eukaryotic cytosolic TrpRSs?
Experimental Procedures
Construction of pet28-His-BsTrpRS Vector—The full-length
BsTrpRS sequence was PCR-amplified from a pet11 con-
struct made previously in the laboratory. PCR primers con-
tained restriction sites for BamHI and HindIII. The resultant
PCR product was digested with BamHI and HindIII. A three-
way ligation among the PCR product (BamHI/HindIII), dou-
ble-stranded oligo encoding for the TEV site (NdeI/BamHI),
and pet28b (NdeI/HindIII) yielded an expression vector for
His-TEV-BsTrpRS.
Expression and Purification of His-BsTrpRS—BsTrpRS was
expressed by autoinductionwith BL21(DE3)pLysS cells at 37 °C
(15). The cells were pelleted at 4500 rpm for 30 min, resus-
pended in lysis buffer, and frozen at 20 °C. Upon thawing,
cells were sonicated and centrifuged (16,000 rpm, 4 °C, 1 h).
His-BsTrpRS was captured from the lysate on nickel-nitrilotri-
acetic acid resin and eluted with 0.3 M imidazole. Purified pro-
tein was cleaved overnight with TEV while dialyzing out the
imidazole. The cleaved protein mixture was passed back over a
nickel-nitrilotriacetic acid column to capture both uncleaved
protein and His-TEV protease.
Active Site Titration—Active sites were titrated by following
the loss of ATP to determine the fraction of molecules compe-
FIGURE 1. Functional equivalences of tryptophan and indolmycin. Indol-
mycin differs from tryptophan in three key ways: 1) the incorporation of C
constituents into an oxazolinone ring, 2) a methylamino group extending
from the oxazolinone ring, and 3) replacement of a hydrogen on C with a
hydrophobic methyl group.
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tent for catalysis (16, 17). The reaction was performed at 37 °C
in a final reactionmixture containing 5000 cpm/l [-32P]ATP,
10 M ATP, 0.5 mM tryptophan, 5 mM MgCl2, and 0.05 unit/l
inorganic pyrophosphatase. The reaction was initiated with
enzyme at a final concentration of 3 M. At various time points
between 10 s and 30min, 3l of the reactionwere added to 6l
of quench buffer (sodium acetate, pH 5.3, 1% SDS) and placed
on ice. Three microliters of each quenched reaction were spot-
ted onto a cellulose-PEI TLC plate and run in 0.75 M KH2PO4,
pH 3.5 with 4 M urea to separate 32Pi and [-32P]ATP. Plates
were developed using a Typhoon imager and analyzed with
ImageJ (18) and JMP (19).
Michaelis-Menten Kinetics—The incorporation of [32P]PPi
into ATPwas tracked either by TLC or filter binding after puri-
fication on charcoal (17). Reactions contained [32P]PPi (5000
cpm/l for TLC and 400 cpm/l for the filter assay), 0.1 M Tris,
pH 8.0, 70 mM -mercaptoethanol, 5 mM MgCl2, 10 mM KF, 2
mMPPi, 2mMATP, and tryptophan ranging from0.3 to 100M.
Reactionswere initiatedwith enzyme at a final concentration of
30 nM.
Indolmycin Inhibition Assays—Inhibition assays were per-
formed as described above; Michaelis-Menten experiments for
tryptophan were performed in the presence of stoichiometric
amounts of indolmycin (a gift from Pfizer, ca. 1994) to enzyme.
Indolmycin to enzyme ratios of 1:5, 1:1, and 5:1 were used, and
results were fitted to a competitive inhibition model (1) using
JMP (19). Non-linear regression to Equation 1 allowed for
determination of Km for tryptophan and Ki for indolmycin.
Rate
Tryptophan kcat
1	 IndolmycinKi 	 Tryptophan
(Eq. 1)
Differential Scanning Fluorimetry (Thermofluor)—The ef-
fects of ATP, tryptophanamide (LTN), and indolmycin on the
thermal stability of BsTrpRS were assessed by thermofluor.We
showed separately3 that differential scanning fluorimetry
detects a conversion of TrpRS into a molten globule form that
fully denatures only at higher temperature. The following sat-
urating ligand concentrations were used to ensure a predomi-
nance of conformations corresponding to those observed in
crystal structures: 5 mM ATP, 5 mM MgCl2, 10 mM LTN, and
600 M indolmycin. All reactions contained 8 M BsTrpRS, 50
mMNaCl, 5 mM -mercaptoethanol, 50 mMHepes, pH 7.5, and
0.15% SYPRO Orange in a final volume of 20 l. Fluorescence
intensities were determined using an Applied Biosystems
7900HTFast Real Time PCR instrument, and data were ana-
lyzed with MATLAB (Mathworks) with routines developed by
Visinets, Inc. The software was built as a pipeline of several
m-files connected to provide full analysis of the data, including
thermodynamic characterization and presentation of statistics.
Fluorescence at each data point along a melting curve is
assumed to be the sum of contributions from two states with
probabilities p1 and p2 established by thermodynamic equilib-
rium between the two states.
Ft	  a1 	 b1T	  p1 	 a2 	 b2T	  p2 (Eq. 2)
where a1 and a2 are adjustable parameters representing inter-
cepts, b1 and b2 are the slopes of the linear dependences of the
initial and final states, and T is the Kelvin temperature. The
pipeline consists of the following three parts.
Part A is reading the data from high throughput, 384-well,
real time PCR files and transforming them into a matrix con-
sisting of four columns: (i) number of the well from which
temperature-dependent readings were taken, (ii) an index rep-
resenting the protein variant, and finally the data, (iii) temper-
ature and (iv) fluorescence readings.
Part B is fitting the thermofluor data to a thermodynamic
model (Equations 3 and 4).
F  F0 	
a1 	 b1T 	 a2 	 b2T	e

GT	/RT
1	 e
GT	/RT
 F0	 a2	 b2T		
a1
 a2		 b1
 b2	T
1	 e
GT	/RT
(Eq. 3)
where
G is theGibbs energy difference between the two states
and e
G(T)/RT is the Boltzmann factor that determines the
state probabilities p1 and p2.

G  
HTm	 	 
cp  T 
 Tm	 
 T
STm	 	 cpln TTm
(Eq. 4)
where 
H and 
S are the enthalpy and entropy changes
between the states, cp is the heat capacity at temperatureT, and

cp is the heat capacity change between the two states at the
melting temperature Tm.
Part C is independent determination ofTm assuming that the
state probabilities p1 and p2 can be estimated from distances
between the intersection of themelting curvewith vertical lines
connecting the extrapolated linear final and initial slopes. Data
initially worked up using both methods B and C agreed closely,
and the analysis reported here follows C.
Crystallization, Data Collection, and Structure Determina-
tion—Crystals of seleno-Met-substituted BsTrpRS in complex
with ATP, Mg2, and indolmycin were grown by vapor diffu-
sion against a reservoir of 1.4 M potassium citrate and 0.1 M
Hepes, pH 7.4. Crystals were cryoprotected in Fomblin-Y and
passed in a nitrogen airstreambefore plunging into liquid nitro-
gen. Data were collected remotely at Southeast Regional Col-
laborative Access Team (Beamline ID-22) using inverse beam
geometry at 0.979 Å to obtain experimental phases from the
Bijvoet differences and processed with XDS (20). PHENIX (21)
and Coot (22) were used for phase determination, to interpret
the map, and to iteratively refine the final structure (Protein
Data Bank code 5DK4).
Results
BsTrpRS Binds Indolmycin 1500 More Tightly than
Tryptophan—Indolmycin is a competitive inhibitor of Bacillus
stearothermophilus and other bacterial TrpRS enzymes that
competes with tryptophan for binding to the active site of the
enzyme. By conducting Michaelis-Menten experiments at3 V. Weinreb and G. Weinreb, unpublished data.
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increasing tryptophan concentrations in the presence of differ-
ent indolmycin concentrations and fitting all 64 data points
simultaneously to Equation 1, we were able to determine
Km,tryptophan (3 M) and Ki,indolmycin (2 nM) (Table 1). As these
experiments were carried out under exchange conditions (23),
we determined the standard free energy,
G0RTlnK, at 310
K for tryptophan and indolmycin binding to be 7.8 and 12.3
kcal/mol, respectively. This translates to a free energy differ-
ence of 4.5 kcal/mol between the affinities of the catalytic and
inhibited complexes for the indole-containing ligand. To deter-
mine what factors account for the observed difference in
binding free energy, we determined the structure of the
BsTrpRSATPindolmycin ternary complex and then con-
ducted differential scanning fluorimetric experiments in the
presence of various ligands.
Indolmycin andATP FormaTernary Complex with BsTrpRS—
Extensive crystallization studies conducted on BsTrpRS have
revealed three distinct conformational states: an open confor-
mation (ligand-free, tryptophan, low ATP (12, 24)), a closed
pre-transition state (high ATP, ATP  tryptophanamide (9,
12)), and a closed product conformation (Trp-5-AMP (25,
26)).
A previously unpublished structure of BsTrpRS bound to
Mg2ATP and indolmycin was never deposited (27). Never-
theless, that structure was the first example of a series of sub-
sequently solved structures that have been described as “pre-
transition state” (PreTS) structures (Protein Data Bank codes
1MAU and 1M83 (12)). In these structures, the initial ATP
binding site in the small domain composed of the N-terminal
-helix and the anticodon-binding domain closes on the
remainder of the Rossmann fold, bringing the nucleotide
-phosphate from 6.7 Å away to within van der Waals contact
distance of the tryptophan carboxyl oxygen (12).
The new structure presented here is at higher resolution (1.9
versus 2.4Å), and the experimental phases greatly enhanced the
quality of electron density maps (Table 2 and Fig. 2). Details of
the new structure, such as the orientation of the ribose and the
metal position, are quite similar to those observed in deposited
PreTS structures 1MAU and 1M83. Detailed differences that
appear functionally relevant are discussed below.
Indolmycin Induces New Contacts with Active Site Side
Chains—Indolmycin makes contacts with the side chains of
His43, Asp132, and Gln147 as well as two water molecules (Fig.
3A). The interaction between O2 of Asp132 in the specificity
helix and the nitrogen atom of the indole ring is observed when
tryptophan (3.1 Å), tryptophanamide (3.0 Å), or indolmycin
(2.9 Å) is bound. The addition of the oxazolinone group to the
ligand allows for stabilizing interactions with His43 and Gln147
with functionalities on either side of the ring, which have the
effect of fixing the rotation of the ring (Fig. 3B). N1 ofHis43 can
donate and/or accept a hydrogen bond from N2 (methylamino
group) of indolmycin. In addition to these hydrogen bonds,
His43 can form a salt bridge with O2 of Asp132 (2.8 Å). The
amide group of Gln147 forms two hydrogen bonds, one with the
carbonyl oxygen of the oxazolinone ring (3.0 Å) and another
with O2 of Asp146 (3.0 Å). O1 of Asp146 makes a highly con-
served hydrogen bond with the 2-OH group of ATP (2.7 Å).
These side chain interactions in the conserved GEDQ motif
link the indolmycin andATPbinding siteswhile reinforcing the
linkage between opposite sides of the indole-binding pocket.
Structurally, indolmycin binding also prevents the Tyr125
rotamer switch that occurs upon the enzyme going from its
open to closed conformation (Fig. 4, A and B). During the cat-
alytic cycle, Tyr125 changes hydrogen-bonding partners from
His150 (2.7 Å) in the open conformation to the -amino group
(2.4 Å) of the tryptophan substrate in the closed PreTS. The
tryptophanyl-adenylate intermediate is stabilized by two polar
contacts with the hydroxyl group of Tyr125 (Protein Data Bank
code1I6K). The inhibited state maintains the side chain inter-
action between Tyr125 and His150 (2.8 Å) observed in the open
state.
Structural Modifications Induced by Indolmycin to the
Mg2ATP Configuration—Superposition of the inhibited
structure onto the closed PreTS structure (Protein Data Bank
code 1MAU) gives a root mean square deviation of 0.28 Å for
323 C pairs. For comparison, the two closed PreTS structures,
TABLE 1
Steady-state kinetic analysis of indolmycin inhibition
Non-linear regression analysis of 64 data points from steady-state kinetics experiments confirms indolmycin as a tight binding competitive inhibitor of BsTrpRS. PPi
exchange assays performed in the presence of saturatingMg2ATPwith varying concentrations of tryptophan and indolmycin show that BsTrpRS binds indolmycin1450
times more tightly than tryptophan. The difference in free energy between the catalytic and inhibited complexes is4.5 kcal/mol.
kcat Gkcat Km,tryptophan GKm Ki,indolmycin GKi Km,tryptophan/Ki,indolmycin
s1 kcal/mol M kcal/mol M kcal/mol
31.6 0.8 2.1 0.01 3.0E06 6.4E07 7.8 0.1 2.0E09 5.2E10 12.3 0.1 1.5E03
TABLE 2
Data collection and refinement statistics for crystals of the
BsTrpRSindolmycinMg2ATP complex
Crystallographic data, including experimental phases, of selenomethionylated
BsTrpRS crystals were collected on Beamline ID-22. The final structure was deter-
mined to 1.9-Å resolution and refined to an Rwork/Rfree of 16.9/18.9%. r.m.s., root
mean square.
Data collection
Space group P43212
Cell constants
a, b, c (Å) 62.04, 62.04, 219.06
, ,  (°) 90.00, 90.00, 90.00
Resolution (Å) 43.02–1.9
Completeness (%)a 99.7 (97.9)
CC1/2 (%)a,b 99.6 (93.2)
Rmeas (%)a 15.3 (61.9)
Mean I/Ia 12.6 (3.3)
Number of reflections 464,942
Multiplicity 15.5
Refinement
Rwork/Rfree (%) 16.6/18.7
Fo, Fc correlation 0.96
r.m.s. bonds 0.005
r.m.s. angles 0.994
Ramachandran favored (%) 97.0
Ramachandran outliers (%) 0.0
Average B, all atoms (Å2) 32.0
Clash score 2.2
Protein Data Bank code 5DK4
a Highest resolution shell is shown in parentheses.
b CC1/2 is the percentage of correlation between intensities from random half-
data sets.
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1MAU and 1M83, have a rootmean square deviation 0.17 Å for
328 C pairs. The greatest structural difference between the
PreTS and inhibited states occurs around Glu103–Ala120 with a
rootmean square deviation of 0.63 Å for these 18 residues. This
mobile loop, which contains Gln107 and Lys111, is more open by
0.5 Å in the inhibited structure as measured from the P of
ATP to the -carbons of residues Gln107, Lys111, and Lys115.
The carbonyl oxygen of the Gln107 side chain accepts a hydro-
gen bond from thewatermolecule coordinated to theMg2 ion
(2.8 Å) and another from N2 of Gln147 (3.0 Å) in the pre-
transition state. Steric clashing with the constrained Tyr125
rotamer prevents Gln107 from switching rotamers in the inhib-
ited state. As such, the interaction with Gln147 is not observed.
Instead, the side chain of Gln107 accepts a hydrogen bond at
O1 from a water molecule (3.0 Å) and donates a hydrogen
bond at N2 to another water molecule (3.3 Å).
In the pre-transition state, the N atom of Lys111 forms a salt
bridge with the O1 atom of ATP (2.9 Å), which also forms a
strong electrostatic interaction with the catalyticMg2 ion (2.4
Å). This interaction presumably is important for stabilizing the
developing charge on the PPi leaving group released after tryp-
tophan activation. Additionally, in the pre-transition state,
Lys111 is in position to act as a hydrogen bond donor to the one
watermolecule coordinated to theMg2 ion (Fig. 5). The subtle
opening of this loop in the inhibited state weakens the salt
bridge between the Lys111 N atom and the O1 atom of ATP
(3.4 Å) from that observed in the preTS. Now the closest inter-
actions are with three water molecules (2.6, 2.8, and 2.8 Å),
none of which are coordinated directly to the catalytic Mg2
ion so they are not shown in Fig. 5.
Replacement of tryptophan(amide) with indolmycin in the
active site alters the coordination and placement of the Mg2
ion used during the activation step of the aminoacylation reac-
tion. Presumably because its orientation is fixed by the hydro-
gen bonding network described above, the oxazolinone forms
hydrogen bonds with two water molecules. Introduction of
these two water molecules is associated with the movement of
the Mg2 ion into a hexavalent coordination that closely
resembles stable configurations generated in quantum
mechanical simulations of Mg2ATP.4
As is also true in the PreTS structure, the Mg2 ion in the
inhibited BsTrpRS structure coordinates with a non-bridging
oxygen from each phosphate group and three water molecules
(Figs. 3B and 4B), two of which are further stabilized by the
presence of indolmycin. In addition to the three electrostatic
interactions with ATP, only one water molecule was seen to
4 S. Liu, unpublished data.
FIGURE 2. BsTrpRS forms a ternary complex with indolmycin and
Mg2ATP in a closed conformation. A, functionally dimeric BsTrpRS crys-
tallizes with one monomer in the asymmetric unit. B, in addition to indolmy-
cin and ATP, the active site contains a Mg2 ion and three stable water mol-
ecules. The Fo Fc omit map, derived by omitting indolmycin, ATP, Mg
2,
and threewatermolecules from a final round of refinement, contoured to 4.0
 is depicted in green.
FIGURE 3. Hydrogen bonding and electrostatic interactions promote
indolmycin binding and Mg2 coordination within the active site. A,
BsTrpRS residues His43, Asp132, and Gln147make stabilizing contacts with IND
via side chain atoms. The ATP and indolmycin binding subsites are linked via
a hydrogen bond (2.7 Å) between Asp146 and Gln147 of the conserved GXDQ
motif. B, Mg2 forms tight electrostatic interactions (2.0–2.3 Å) with three
water molecules (red spheres) and an oxygen atom from each phosphate
group of ATP. Two of these water molecules are within hydrogen bonding
distance (2.6 and 2.7 Å) of indolmycin.
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coordinate with the Mg2 ion in the PreTS structure (Protein
Data Bank code 1MAU) (Figs. 4A and 5). The side chain resi-
dues that accept and donate hydrogen bonds to this water mol-
ecule differ between these two states (Fig. 5). Due to the differ-
ent Gln107 rotamer and slight opening of the mobile loop
around Lys111, these two residues no longer interact with this
water molecule in the inhibited state.
TheMg2 ion is closer and more central to the triphosphate
moiety in the inhibited structure than in the PreTS structure
(Fig. 4C) andmakes equivalent interactions with the phosphate
oxygen atoms. The significance of the differences inmetal posi-
tions is evident from several measurements. (i)Metal to oxygen
distances are significantly shorter (0.2 Å; p  0.002) in the
inhibited complexes. (ii) Movement of the divalent metal ion
into closer contact with the ATP phosphate oxygen atoms is
associated with a subtle but statistically significant opening of
the active site crevice among theN-terminal helix of the second
crossover connection (the GXDQ motif), the KMSKS signa-
ture, and the mobile loop containing Lys111.
Ligand-induced Stability Changes Imply Cooperative Sources
of High Indolmycin Affinity—The nature of the ligands within
the active site has a significant effect on the conformation and
thermal stability of an enzyme. For small perturbations, the
fractional change inmelting temperature (
Tm/Tm) induced by
ligand binding is proportional to the free energy change in sta-
bility, the proportionality constant being the enthalpy change
(
H) (28). We use this implicit relationship to assess the stabi-
lizing or destabilizing effects of various ligands on the BsTrpRS
enzyme. Binding of ATP, tryptophan, or tryptophanamide sta-
bilizes the thermal transition of molten globule formation by 3,
7, and 7%, respectively (Table 3). Indolmycin enhances the ther-
mal stability of BsTrpRS by 20%, increasing Tm by 13.5 °C. The
enhanced affinity for indolmycin over tryptophan results in a
shift by 8 °C to higher temperature in the thermal transition due
to molten globule formation in the presence of indolmycin
compared with tryptophan.
The linkage between protein stability and ligand binding
(29–31) implies that we can attribute differences in stability
changes to binding affinity. Two of the stabilizing interactions
formed between indolmycin and Mg2-coordinated water
molecules are associated with a change in the metal position
relative to the ATP phosphate oxygen atoms. A key implication
of the structural observations in Figs. 3A and 4C is that binding
of indolmycin to BsTrpRS should be potentiated by the pres-
ence of Mg2ATP.
FIGURE4.Comparisonof ligand-free, preTS, and inhibitedBsTrpRS struc-
tures. A, compared with the apo form (pink; Protein Data Bank code 1D2R),
the fully occupied PreTS structure (black; Protein Data Bank code 1MAU)
assumes a closed conformation. The C of Tyr125 is shifted inward by 2.4 Å,
and the side chain is flipped 45° (measured from OH-Ca-OH). A Mg2 ion
(black sphere) forms electrostatic interactions with ATP and one water mole-
cule (salmon sphere). B, binding of indolmycin and ATP causes similar shifts in
the backbone (gray) as the enzyme adopts a closed conformation. However,
due to the addition of the methylamino-substituted oxazolinone ring, this
movement to the closed conformation is not accompanied by a rotamer
change of Tyr125 in the inhibited structure. C, consequently, Gln107 is con-
strained and is rotated 106° around C away from the specificity helix in the
inhibited state compared with the pre-transition state. Finally, the Mg2
(green sphere) is shifted toward the PO4 and has hexavalent coordination to
ATP and three water molecules (red spheres) as compared with the preTS
structure.
FIGURE 5. Differential BsTrpRS side chain interactions with the water
molecules electrostatically coordinated with Mg2 in the PreTS and
inhibited structures. Gln9, Gln107, and Lys111 are in position to accept
(Gln107) or donate (Gln9 and Lys111) hydrogen bonds (black dashed lines) to
the water molecule (salmon sphere) coordinated with Mg2 (black sphere) in
the PreTS (black sticks). As indolmycin binding leads to opening of themobile
loop containingGln107 and Lys111, these residues are too far (red dashed lines)
to form stabilizing interactions with the equivalent water molecule (red
sphere) in the inhibited complex (gray sticks). The three water molecules (red
spheres) electrostatically coordinated to Mg2 (green sphere) in the inhibited
complex are stabilized by interactions (cyan dashed lines) with side chain
atoms of residues Gln9, Asp146, Gln147, and Lys192.
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The presence/position of Mg2 in the active site is strictly
dependent on ATP because the proteinmakes no contacts with
the metal. As no direct ATP-indolmycin interactions are
observed, we therefore expected that ATP would enhance the
thermal stability of the BsTrpRSindolmycin complex by a
larger amount in the presence compared with the absence of
Mg2. Additionally, we did not expect Mg2 to contribute to
thermal stability in the absence of ATP. As expected, the differ-
ential scanning fluorimetry measurements show that the
BsTrpRS in complexwith indolmycin andMg2ATPhas a 27%
increase in melting temperature compared with ligand-free
enzyme with Mg2ATP contributing an additional 5 °C of
thermal stability on top of the 13.5 °C provided by indolmycin
binding. By contrast, binding of indolmycin, indolmycin 
Mg2, or indolmycin  ATP all elicit far smaller changes of
20% in thermal stability, demonstrating that both Mg2 and
ATP are required to confer additional thermal stability to the
BsTrpRSindolmycin (IND) complex.
The conclusion that the metal is essential to the enhanced
affinity of indolmycin to the pre-transition state complex can
also be derived using the three-dimensional thermodynamic
cycle of contributions to stability from ATP, the methylamino-
substituted oxazolinone ring (OXA), and the presence/absence
of Mg2 (Fig. 6). Differences in binding and thermal stability
between tryptophanamide and indolmycin were attributed to
the methylamino-substituted oxazolinone ring as this is the
major structural difference between these two ligands.
Stabilizing and destabilizing interactions are distinguished
by positive and negative non-additivity, respectively. If thermal
stability were unaffected by interactions between the ligands,
then we expect the effects of binding multiple ligands, e.g. ATP
and LTN, to be additive and the effects of binding one ligand
not to be affected by the presence of a second ligand, thus giving
Equations 5 and 6.

Tm(ATP) 
Tm(LTN)
TmATP LTN) (Eq. 5)

Tm(LTN)  Tm(LTN) Tm(LF)
 Tm(ATP LTN) Tm(ATP) (Eq. 6)
An interaction between the ligands would introduce a term,

Tm,int, to describe the non-additivity (32), giving Equation 7.

Tm(ATP) 
Tm(LTN)
Tm,int
Tm(ATP LTN)
(Eq. 7)
In the absence ofMg2, there is no significantATP-OXA inter-
action, and binding either IND or LTN reduces the effect of ATP
on Tm by1.5 °C. The ATP-LTN and ATP-IND interactions are
bothdestabilizing; i.e. thedoubly ligandedcomplexesmelt at lower
temperatures. In contrast, addition ofMg2 stabilizes the interac-
tions of ATPwith LTN and IND to varying degrees. In the case of
LTN-ATP, addition of Mg2 compensates for the destabilizing
ATP-LTN interaction such that the interaction is no longer signif-
icant. The metal compensates for the1.3 °C destabilizing ATP-
INDinteractionandallows foranadditional stabilizing interaction
of 2.6 °C. Thus, the 
Tm (ATP-OXA) interaction is comparable
with that of the
Tm (ATP-IND) interaction.The crystal structure
suggests that the stabilizing effect of Mg2 on the interaction
FIGURE 6. Contributions of Mg2, ATP, indolmycin, and tryptophana-
mide to the thermal stability of BsTrpRS. TrpRS enzymes require a Mg2
ion for tryptophan activation. Although Mg2 does not change the thermal
stability of BsTrpRS on its own, its presence or absence significantly impacts
the interaction of ATP with both LTN and IND. In the absence of Mg2 (top
row), both the ATP-LTN andATP-IND interactions lower the fractional change
inTmby2%from its expectedvalue. In thepresenceofMg
2 (bottomrow), the
interaction between ATP and LTN is insignificant, whereas the ATP-IND inter-
action raises the Tm 4% higher than expected. As expected from the crystal
structure, theMg2-dependent ATP-IND interaction ismediated through the
oxazolinone moiety of indolmycin. LF, ligand-free.
TABLE 3
Thermofluor analysis of ligand-dependent stability
Differential scanning fluorimetric analysis of ligand-dependent thermal stability of BsTrpRS revealed a stabilizing interaction between indolmycin and ATP via Mg2.
Substrates (ATP and tryptophan) and substrate analogs (LTNand IND) induce conformational changes in BsTrpRS. These changes varywith ligand type and confer varying
degrees of thermal stability in the transition to molten globule formation. ATP, tryptophan, tryptophanamide, and indolmycin separately enhance the thermal stability of
BsTrpRS. Mg2 is required for additional stabilization by ATP of both LTN-bound and IND-bound BsTrpRS. The inhibited complex (BsTrpRS bound with IND and
Mg2ATP) is the most thermally stable with a Tm 18.4 and 10.7 °C higher than that of ligand-free (LF) enzyme and PreTS complex, respectively. n/a, not applicable.
Ligand Mg2 Tm Tm (Tm/Tm) 100
°C °C %
LF  69.0 0.2 n/a n/a
ATP  71.1 0.1 2.1 0.2 3.0 0.2
TRP  74.7 0.1 5.7 0.3 8.2 0.4
LTN  74.1 0.1 5.1 0.3 7.4 0.4
LTN ATP  74.7 0.2 5.7 0.2 8.3 0.3
IND  82.5 0.2 13.5 0.3 19.6 0.5
IND ATP  83.3 0.3 14.3 0.4 20.7 0.6
LF  69.0 0.1 n/a n/a
ATP  71.2 0.03 2.2 0.1 3.1 0.2
TRP  74.1 0.1 5.1 0.1 7.4 0.1
LTN  74.2 0.2 5.1 0.2 7.4 0.3
LTN ATP  76.8 0.2 7.7 0.1 11.2 0.2
IND  82.7 0.04 13.6 0.2 19.7 0.3
IND ATP  87.5 0.1 18.4 0.2 26.7 0.4
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between ATP and indolmycin is mediated through the oxazolin-
one ring, whose orientation is, in turn, stabilized by hydrogen
bonds to His43 and Gln147 as discussed above.
Discussion
An array of crystal structures of both BsTrpRS and HcTrpRS
provide snapshots of the enzymes along their catalytic paths
and demonstrate the conformational changes that result from
binding of various ligands (12, 13, 24). From these structures, it
is evident thatHcTrpRSuses a greater number of binding deter-
minants for tryptophan recognition and that binding of trypto-
phan causes an induced fit rearrangement of the active site in
HcTrpRS but not BsTrpRS. Here we discuss possible structural
and mechanistic reasons for the tight binding of indolmycin to
BsTrpRS and the inability of indolmycin to inhibit eukaryotic
TrpRSs.
Why Is Indolmycin a High Affinity Inhibitor of Bacterial
TrpRS?—There are no drastic global changes between struc-
ture 1MAU and the inhibited BsTrpRS structure (Protein Data
Bank code 5DK4). We propose that subtle, mechanistically rel-
evant differences in the active site metal configuration account
for the ability of indolmycin to inhibit BsTrpRS as tightly as it
does. We observe stronger Mg2-ATP and weaker BsTrpRS-
ATP interactions (Fig. 6) as well as altered Mg2 coordination
and placement in the inhibited state (indolmycinMg2ATP;
Figs. 3B and 4) compared with the pre-transition state (trypto-
phanamideMg2ATP) structure. We attribute these differ-
ences to the replacement of tryptophanamide with indolmycin
that varies mainly at the methylamino-substituted oxazolinone
ring of indolmycin. Interactions among His43, Gln147, and
indolmycin restrict the oxazolinone ring orientation, thereby
reducing the entropy of the -carbon mimic in the inhibited
complex compared with the pre-transition state complex. This
unfavorable entropy change is compensated by the enthalpy
from additional hydrogen bonds formed among the Mg2-co-
ordinated water molecules and the oxazolinone nitrogen and
carbonyl oxygen atoms as well as the interaction with His43.
These hydrogen bonds stabilize the water molecules that are
also tightly coordinated to the catalytic Mg2 ion. Functional
groups of the -carbon atoms of tryptophan and tryptophana-
mide can adopt alternative conformations that are similar in
energy, none of which allow for completion of the Mg2 coor-
dination sphere. We conclude from these observations that
completion of that coordination sphere allows the metal to
form significantly tighter interactions with all three phosphate
oxygen atoms and hence that indolmycin stabilizes a ground
state Mg2ATP configuration, opposing the tendency of the
PreTS state to promote the metal to a high energy state that
assists in transition state stabilization.
Furthermore, the oxazolinone ring of indolmycin, stabilized
by hydrogen bondswithHis43 andGln147, prevents the rotamer
switch of Tyr125 in the specificity helix that is part of the struc-
tural transition from the open to the closed state. To avoid a
steric clashwith the constrained Tyr125 residue, Gln107 likewise
does not switch rotamers in the presence of indolmycin. Gln107
is part of a highlymobile loop that shows a subtle but significant
opening in the inhibited state comparedwith the pre-transition
state. This opening results in the weakening of ATP-BsTrpRS
interactions, specifically those between Lys111 and the -phos-
phate group.
In the catalytically competent PreTS configuration, coordi-
nation by lysine residues of the phosphate oxygen atoms pro-
motes the metal to an activated, less stable state with weaker
interactions to the three phosphate oxygen atoms and prevents
the Mg2 ion from assuming a lower energy position with
stronger contacts to ATP. The positively charged N atom of
Lys111 competes with the Mg2 ion for stabilization of a nega-
tively charged oxygen atom (O) of the -phosphate group. In
the PreTS state, the Mg2-O and Lys111-O distances are 2.4
and 2.9 Å, respectively.
Substitution by indolmycin for tryptophanamide simultane-
ously weakens the Lys111-O (3.4 Å) interaction and strength-
ens that between that oxygen atom and the Mg2 ion (2.2 Å).
Additionally, the 0.4-Å shift in Mg2 placement along with the
opening of the mobile loop around Lys111 allows for tight,
hexavalentMg2 coordination accompanied by stronger, more
nearly equivalent interactions between Mg2 and the three
ATP phosphate groups.
Mutation of His43 Results in Indolmycin Resistance—When
both tryptophanamide andATP are bound, theHis43 side chain
switches from one rotamer to another in the transition from
open to closed PreTS state and back again in the closed product
state. This rotamer switch does not occur when the active site is
bound to AMP, PPi, and tryptophan (33). In the PreTS
(Mg2ATP LTN) and inhibited (Mg2ATP IND) states,
N2 of His43 interacts with O2 of Asp132. In all other observed
states, N2 of His43 forms an interaction with the carbonyl oxy-
gen of Tyr125. His43 also contributes to indolmycin binding via
N1. This reorientation of His43 appears to be correlated with
the succession of ligands most similar to the putative catalytic
reaction path, and it may thus also be functional.
Several groups have identified mutations that confer high
level indolmycin resistance (34–36). One of the mutant sites,
His43, is of direct interest in the context of the present inhibited
structure, which furnishes a semiquantitative explanation for
the mutational effects at position 43.We have implicated His43
in a hydrogen bond network that requires hydrogen bonds to
both indole nitrogen atoms that stabilize the orientation of the
plane of the oxazolinone ring of indolmycin. Fixing the orien-
tation of the ring consequently allows formation of a full hexa-
coordinated environment for the catalytic Mg2 ion, which we
have shown accounts for the additional stabilization of the
indolmycinMg2ATP complex.
Indolmycin inhibition of the B. stearothermophilus TrpRS
H43N mutant is weaker by 3.5 kcal/mol than that of the native
enzyme (37). Depending on the stabilization energy provided
by these two hydrogen bonds and their coupling, we would
predict that an H43Nmutant would lose 2–4 kcal/mol binding
energy compared with wild-type enzyme. All rotamers of an
asparagine substitution at position 43would result in the loss of
two of the three hydrogen bonds observed in the network
among indolmycin, His43, and Asp132. Similarly, the homo-
logous H48Q mutation in Streptomyces coelicolor similarly
appears incapable of forming both hydrogen bonds we observe
for His43 (36).
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Modeling Reveals Why Indolmycin Is a Weak Inhibitor of
Eukaryotic Cytosolic TrpRS Enzymes—The selectivity ratio of
indolmycin for cytosolic B. taurus (Bt)TrpRS versus BsTrpRS is
106-fold in favor of BsTrpRS binding. This selectivity factor far
surpasses those of most therapeutic drugs, including trim-
ethoprim (selectivity ratio rat/Toxoplasma gondii dihydrofo-
late reductase, 49) and metoprolol (selectivity ratio 2/1-
adrenergic receptor, 6.0), which treat toxoplasmosis and
cardiovascular disease, respectively (38, 39). This dramatic
selectivity arises by enhancing indolmycin binding recognition
by BsTrpRS as we have just shown while reducing eukaryotic
cytosolic TrpRS affinity by similarmagnitudes.HcTrpRS shares
93% sequence identity with BtTrpRS and is therefore highly
likely to have a comparably weak millimolar affinity for indol-
mycin. Interest in developing indolmycin as a lead compound
for anti-infective therapy as well as the extensive kinetic and
structural studies conducted onHcTrpRS led us to examine the
repertoire of depositedHcTrpRS structures with the purpose of
identifying potential means by which eukaryotic cytosolic
TrpRS enzymes evade inhibition by indolmycin (13, 14, 40, 41).
Whereas BsTrpRS uses an induced fit mechanism for ATP
binding, HcTrpRS uses induced fit for tryptophan binding.
Binding of tryptophan toBsTrpRS is stabilized by one hydrogen
bond between the indole nitrogen of tryptophan and O2 of
Asp132 and - interactions with Phe5. Meanwhile, HcTrpRS
makes seven direct and water-mediated contacts to its trypto-
phan substrate. The determinants for tryptophan binding to
HcTrpRS include Glu199, which has a direct and water-medi-
ated interaction with the -amino group of tryptophan (Fig.
7A). Modeling of indolmycin into the amino acid binding site
introduces steric clashes between indolmycin and Glu199 (Fig.
7B). Furthermore, Glu199 cannot adopt an alternative rotamer
conformation without introducing additional clashes between
Glu199 and Thr196, Trp203, or Phe280. Besides clashing with
Glu199, this indolmycin conformer would not form any of the
hydrogen bonds observed when tryptophan is bound aside
from the bifurcated hydrogen bond with the indole nitrogen,
Tyr159, and Gln194. These interactions are preserved because
indolmycin was modeled into the active site by overlaying its
indole moiety with that of tryptophan (Protein Data Bank code
2QUH).
Indolmycin can be modeled into the active site of HcTrpRS
by rotating the oxazolinone ring away from Glu199 to an orien-
tation perpendicular to the indole moiety (Fig. 7B). Although
this indolmycin conformer does not clash with active site resi-
dues, it does disrupt the hydrogen bonding pattern used by the
cytosolic enzyme to identify tryptophan as the bound substrate.
The-amino group of tryptophan,which is protonated at phys-
iological pH, is recognized by Glu199, Gln284, and Gln313 (Fig.
7A). Each of these residues acts a hydrogen bond acceptor, and
the negatively charged carboxylate of Glu199 forms additional
electrostatic interactions with the amino group. According to
our model, the side chain amide group of Gln284 would act as a
hydrogen bond donor for the cyclic oxygen atom in indolmycin
that is in the equivalent position of the-amino group (Fig. 7B).
Although Glu199 cannot form a salt bridge with indolmycin, it
can instead share a bifurcated hydrogen bond from the meth-
ylamino group nitrogenwithGln313. This nitrogen can accept a
hydrogen bond from the hydroxyl group of Tyr316.
Finally, Lys200 cannot form a salt bridge with indolmycin as it
does with the tryptophan carboxylate. This electrostatic inter-
action is also missing when tryptophanamide is bound in place
of tryptophan and appears to be critical for progression from
the pre-transition state to transition state as this is the only
interaction used for tryptophan substrate recognition and
binding that cannot form when tryptophanamide occupies the
active site. Indolmycin differs from tryptophan by a greater
degree than does tryptophanamide. The inability of indolmycin
to fully retain the tryptophan-HcTrpRS side chain interactions,
including the salt bridge with Lys200, allows HcTrpRS to dis-
criminate between tryptophan and the inhibitor. For these rea-
sons, a stable HcTrpRSATPindolmycin complex is1000 less
likely to form than that ofHcTrpRSATPtryptophan. Contrast-
ingly, BsTrpRS, which has a 103-fold higher affinity for indol-
mycin over tryptophan, is 1500 more likely to form a stable,
inhibited complex than a catalytically competent tryptophan-
bound complex.
FIGURE 7. Steric hindrance and altered hydrogen bonding pattern allow
HcTrpRS todiscriminatebetweentryptophanand indolmycin.A, theelec-
trostatic and hydrogen bonding interactions that facilitate specific recogni-
tion and binding of Trp toHcTrpRS (Protein Data Bank code 2QUH) are shown
in yellow dashes. B, IND (yellow and pink sticks) from the BsTrpRS complexwas
modeled into the tryptophanbinding site ofHcTrpRS (ProteinDataBank code
2QUH) so the indolemoieties superimposed. Thismaintained the H-bonding
interactions between the indole nitrogen and Tyr159 and Gln194. Rigid body
modeling shows that none of the interactions important for tryptophan sub-
strate recognition/binding can form between active site residues and indol-
mycin (yellow sticks). Additionally, rotating the oxazolinone ring away from
Glu199 eliminates a prominent steric clash between the methylamino group
of indolmycin and the side chain carboxylate group of Glu199. This alternate
indolmycin conformation (pink sticks) allows for more hydrogen bonding
interactions between indolmycin and active site residues, although the
nature of these interactions is different from those observed upon trypto-
phan binding. Modeling suggests that these altered interactions allow
HcTrpRS to reject indolmycin as a substrate.
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In this work, we determined the structural basis for high
affinity inhibition of BsTrpRSby indolmycin. The simultaneous
binding of indolmycin and Mg2ATP results in (i) movement
of the Tyr125 and Gln107 side chains, (ii) opening of the mobile
loop containing Lys111, (iii) displacement of theMg2 ion by 0.4
Å, (iv) hexavalent metal coordination, (v) stronger, nearly
equivalent electrostatic interactions of Mg2 with an oxygen
from each phosphate group of ATP, and (vi) weaker coordina-
tion of phosphate group oxygen atoms by active site lysine res-
idues. These changes are reinforced by the hydrogen bonding
interactions of Gln147, His43, and Mg2-coordinated water
molecules with indolmycin.We propose that weaker coordina-
tion by lysine residues of the phosphate oxygen atoms and
stronger Mg2-ATP interactions induced by indolmycin bind-
ing allow the Mg2 ion to settle into a lower energy state,
thereby significantly increasing affinity by preventing activa-
tion of the metal required for use in amino acid activation.
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